Literature DB >> 12874340

The absence of linear plasmid 25 or 28-1 of Borrelia burgdorferi dramatically alters the kinetics of experimental infection via distinct mechanisms.

Maria Labandeira-Rey1, J Seshu, Jonathan T Skare.   

Abstract

The 25-kb linear plasmid lp25 and one of the 28-kb linear plasmids (lp28-1) are required for experimental infection in Borrelia burgdorferi, the etiologic agent of Lyme disease. The loss of these plasmids either eliminates infectivity (lp25) or significantly increases the 50% infective dose during a 2-week infection period (lp28-1). This study assessed the kinetics of bacterial dissemination in C3H/HeN mice infected with B. burgdorferi lacking either lp25 or lp28-1, as well as their wild-type parent, and tracked the development of specific borrelial antibodies over a 3-week period. The results indicated that the wild type and the lp28-1(-) strains were able to disseminate throughout the host, whereas the lp25(-) strain was cleared within 48 h of inoculation. While the wild-type B. burgdorferi persisted in tissues for the duration of the study, the lp28-1(-) mutant began clearing at day 8, with no detectable bacteria present by day 18. As expected, the wild-type strain persisted in C3H/HeN mice despite a strong humoral response; however, the lp28-1(-) mutant was cleared coincidently with the development of a modest immunoglobulin M response. The lp28-1(-) mutant was able to disseminate and persist in C3H-scid mice at a level indistinguishable from that of wild-type cells, confirming that acquired immunity was required for clearance in C3H/HeN mice. Thus, within an immunocompetent host, lp28-1-encoded proteins are not required for dissemination but are essential for persistence associated with Lyme borreliosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874340      PMCID: PMC166013          DOI: 10.1128/IAI.71.8.4608-4613.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice.

Authors:  S W Barthold; D H Persing; A L Armstrong; R A Peeples
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

2.  Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes.

Authors:  J R Zhang; J M Hardham; A G Barbour; S J Norris
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

3.  Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi.

Authors:  C M Fraser; S Casjens; W M Huang; G G Sutton; R Clayton; R Lathigra; O White; K A Ketchum; R Dodson; E K Hickey; M Gwinn; B Dougherty; J F Tomb; R D Fleischmann; D Richardson; J Peterson; A R Kerlavage; J Quackenbush; S Salzberg; M Hanson; R van Vugt; N Palmer; M D Adams; J Gocayne; J Weidman; T Utterback; L Watthey; L McDonald; P Artiach; C Bowman; S Garland; C Fuji; M D Cotton; K Horst; K Roberts; B Hatch; H O Smith; J C Venter
Journal:  Nature       Date:  1997-12-11       Impact factor: 49.962

4.  Therapeutic passive vaccination against chronic Lyme disease in mice.

Authors:  W Zhong; T Stehle; C Museteanu; A Siebers; L Gern; M Kramer; R Wallich; M M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

5.  Correlation of plasmids with infectivity of Borrelia burgdorferi sensu stricto type strain B31.

Authors:  Y Xu; C Kodner; L Coleman; R C Johnson
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

6.  Passive immunizing activity of sera from mice infected with Borrelia burgdorferi.

Authors:  S W Barthold; L K Bockenstedt
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

7.  Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis.

Authors:  G Baranton; D Postic; I Saint Girons; P Boerlin; J C Piffaretti; M Assous; P A Grimont
Journal:  Int J Syst Bacteriol       Date:  1992-07

8.  High- and low-infectivity phenotypes of clonal populations of in vitro-cultured Borrelia burgdorferi.

Authors:  S J Norris; J K Howell; S A Garza; M S Ferdows; A G Barbour
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

9.  Serum-mediated resolution of Lyme arthritis in mice.

Authors:  S W Barthold; M deSouza; S Feng
Journal:  Lab Invest       Date:  1996-01       Impact factor: 5.662

10.  Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi.

Authors:  J R Zhang; S J Norris
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

View more
  98 in total

Review 1.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

2.  CsrA modulates levels of lipoproteins and key regulators of gene expression critical for pathogenic mechanisms of Borrelia burgdorferi.

Authors:  S L Rajasekhar Karna; Eva Sanjuan; Maria D Esteve-Gassent; Christine L Miller; Mahulena Maruskova; J Seshu
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

3.  Borrelia burgdorferi organisms lacking plasmids 25 and 28-1 are internalized by human blood phagocytes at a rate identical to that of the wild-type strain.

Authors:  Samiya Al-Robaiy; Jens Knauer; Reinhard K Straubinger
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 4.  Evolution and population genomics of the Lyme borreliosis pathogen, Borrelia burgdorferi.

Authors:  Stephanie N Seifert; Camilo E Khatchikian; Wei Zhou; Dustin Brisson
Journal:  Trends Genet       Date:  2015-03-09       Impact factor: 11.639

5.  Role of the BBA64 locus of Borrelia burgdorferi in early stages of infectivity in a murine model of Lyme disease.

Authors:  Mahulena Maruskova; M Dolores Esteve-Gassent; Valerie L Sexton; J Seshu
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

6.  Role of Borrelia burgdorferi linear plasmid 25 in infection of Ixodes scapularis ticks.

Authors:  Keith O Strother; Aravinda de Silva
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

Review 7.  Biology of infection with Borrelia burgdorferi.

Authors:  Kit Tilly; Patricia A Rosa; Philip E Stewart
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

8.  Essential protective role attributed to the surface lipoproteins of Borrelia burgdorferi against innate defences.

Authors:  Qilong Xu; Kristy McShan; Fang Ting Liang
Journal:  Mol Microbiol       Date:  2008-04-28       Impact factor: 3.501

9.  Protective niche for Borrelia burgdorferi to evade humoral immunity.

Authors:  Fang Ting Liang; Eric L Brown; Tian Wang; Renato V Iozzo; Erol Fikrig
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

10.  The BosR regulatory protein of Borrelia burgdorferi interfaces with the RpoS regulatory pathway and modulates both the oxidative stress response and pathogenic properties of the Lyme disease spirochete.

Authors:  Jenny A Hyde; Dana K Shaw; Roger Smith Iii; Jerome P Trzeciakowski; Jon T Skare
Journal:  Mol Microbiol       Date:  2009-11-10       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.